The government alleges Labcorp and UHS delayed submission of orders for tests by Caris Life Sciences to enable improper billings to Medicare for those tests.

NEW YORK – Anbio Biotechnology filed this week a preliminary prospectus for an initial public offering on the Nasdaq exchange of 1.6 million shares at an anticipated offering price in the range of $5 ...

The firm received notice that it had failed to regain compliance with the Nasdaq's requirement to maintain a minimum $35 million market value of listed securities.

The funding will be used to move the ARGO-HT research platform into an FDA-cleared system to support the development of diagnostic tests.

Physicians Toxicology Laboratory had been accused of encouraging client healthcare practices to order drug tests for all patients regardless of medical need.

The firm said that the unsecured $1.5 billion revolving credit facility through 2030 replaces another $1.5 billion credit facility through 2026.

Rounding out the other four largest financing rounds in 2024 are proteomics company Alamar Biosciences' $128 million Series C funding round, Karius' and Cytovale's $100 million raises, and early ...

FDA officials said that the draft guidance is meant to address recommendations from two reports on the agency's response to COVID-19.

The funding will be used to expand the firm's global services, enhance its core platforms, and accelerate the development of pathology foundational models.

The bank upgraded Labcorp's stock on expectations of solid lab volume growth, accretive revenues from Labcorp's Invitae business, and margin expansion in 2025.

Last week, readers were most interested in a story about the progress made by test developers toward commercializing rapid tests for sepsis.

NEW YORK – After two years of decline in 2022 and 2023, the 360Dx Top 30 rebounded in 2024, rising 4 percent year over year.